Company / Current Assets per Share
Vertex Pharmaceuticals Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$43.59
FY2025
5-year range
$36.79 / $55.03
FY2021-FY2025
Trend
+17.1%
vs FY2024
Sector context
#12 of 210
Health Care
What the data says
Among 210 Health Care companies, Vertex Pharmaceuticals is in the top 6% for current assets per share. Declined from $55.03 to $43.59 over the past 2 years.
Based on SEC 10-K filings.
43.59 in FY2025 with a 5-year CAGR of +6.8%. Top quartile in the Health Care sector.
Declined from $55.03 to $43.59 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -5.7%
- 5-Year CAGR
- +6.8%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 210This company $43.59 Sector average $170.65
▼
-74.5% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 17.1% year-over-year.
- Ranks #12 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2023.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 31.4%
- Strong return on equity: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $43.59 | +17.1% |
| FY2024 | $37.24 | -32.3% |
| FY2023 | $55.03 | +5.8% |
| FY2022 | $52.01 | +41.4% |
| FY2021 | $36.79 | +17.1% |
| FY2020 | $31.40 | +66.2% |
| FY2019 | $18.90 | +24.5% |
| FY2018 | $15.17 | +42.2% |
| FY2017 | $10.67 | +43.5% |
| FY2016 | $7.44 | +27.8% |
As of FY2025 · SEC 10-K · Updated Mar 17, 2026